Valuations of life sciences businesses declined in the wake of the global pandemic, but government stimulus and medical breakthroughs point to brighter days.
Investcorp took on $125 million of debt to finance distributions to investors in its $620 million fund to back general partners of private-market investment pools, according to a person familiar with the matter.